tradingkey.logo

KORU Medical Systems Inc

KRMD

3.350USD

-0.130-3.74%
Horarios del mercado ETCotizaciones retrasadas 15 min
154.57MCap. mercado
PérdidaP/E TTM

KORU Medical Systems Inc

3.350

-0.130-3.74%
Más Datos de KORU Medical Systems Inc Compañía
KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Información de la empresa
Símbolo de cotizaciónKRMD
Nombre de la empresaKORU Medical Systems Inc
Fecha de salida a bolsaOct 27, 1993
Director ejecutivoMs. Linda M. Tharby
Número de empleados80
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 27
Dirección100 Corporate Drive
CiudadMAHWAH
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal07430
Teléfono18454692042
Sitio Webhttps://www.korumedical.com/
Símbolo de cotizaciónKRMD
Fecha de salida a bolsaOct 27, 1993
Director ejecutivoMs. Linda M. Tharby
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.09M
+16.34%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
87.60K
+5.02%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
84.97K
+5.19%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
84.61K
+5.21%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
37.77K
+12.47%
Adam Kalbermatten
Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.09M
+16.34%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
87.60K
+5.02%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
84.97K
+5.19%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
84.61K
+5.21%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
37.77K
+12.47%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por negocioUSD
Nombre
Ganancia
Proporción
Domestic Core
6.93M
71.90%
International Core
2.43M
25.21%
Novel Therapies
278.45K
2.89%
Por regiónUSD
Nombre
Ganancia
Proporción
Domestic
7.21M
74.79%
International
2.43M
25.21%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Domestic Core
6.93M
71.90%
International Core
2.43M
25.21%
Novel Therapies
278.45K
2.89%
Estadísticas de accionistas
Actualizado: vie., 1 de ago
Actualizado: vie., 1 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Horton Capital Management LLC
12.73%
First Light Asset Management, LLC
10.22%
Topline Capital Management, LLC
8.28%
Tharby (Linda M)
4.53%
The Vanguard Group, Inc.
3.82%
Other
60.42%
Accionistas
Accionistas
Proporción
Horton Capital Management LLC
12.73%
First Light Asset Management, LLC
10.22%
Topline Capital Management, LLC
8.28%
Tharby (Linda M)
4.53%
The Vanguard Group, Inc.
3.82%
Other
60.42%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
25.85%
Investment Advisor/Hedge Fund
14.56%
Investment Advisor
9.44%
Individual Investor
7.65%
Research Firm
1.32%
Pension Fund
0.81%
Other
40.36%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
179
27.81M
60.29%
+1.08M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
2023Q3
138
32.73M
71.92%
-2.69M
2023Q2
140
33.07M
72.70%
-1.19M
2023Q1
149
31.99M
70.39%
-2.55M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Horton Capital Management LLC
5.87M
12.73%
-16.19K
-0.27%
Apr 02, 2025
First Light Asset Management, LLC
4.71M
10.22%
+259.46K
+5.82%
Apr 30, 2025
Topline Capital Management, LLC
3.82M
8.28%
-505.93K
-11.69%
Mar 31, 2025
Tharby (Linda M)
2.09M
4.53%
+293.63K
+16.34%
Apr 21, 2025
The Vanguard Group, Inc.
1.76M
3.82%
+6.48K
+0.37%
Mar 31, 2025
Meros Investment Management, LP
746.56K
1.62%
-18.99K
-2.48%
Mar 31, 2025
Millennium Management LLC
603.21K
1.31%
+319.50K
+112.62%
Mar 31, 2025
Archon Capital Management LLC
566.87K
1.23%
+377.97K
+200.09%
Mar 31, 2025
Manko (Joseph M JR)
517.20K
1.12%
--
--
Apr 02, 2025
Geode Capital Management, L.L.C.
495.27K
1.07%
+32.09K
+6.93%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Global X Russell 2000 Covered Call ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 ETF
0%
Ver más
iShares Micro-Cap ETF
Proporción0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.03%
Global X Russell 2000 ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
Global X Russell 2000 Covered Call ETF
Proporción0%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI